Ernexa Therapeutics Inc. (ERNA) investor relations documents from the company's IR site: 2 presentations; latest deck 2026-04-08. Read in-app with summaries. First-party data.
Download PDF: Ernexa Therapeutics is a preclinical-stage company developing synthetic, off-the-shelf iMSC therapies, targeting an IND submission for ERNA-101 by Q3 2026.
| Published | Type | Document |
|---|---|---|
| 2026-04-08 | Presentation | Download PDF |
| 2026-04-07 | Presentation | Download PDF |
ERNA overview · ERNA earnings · ERNA financials · ERNA KPIs · ERNA ownership · ERNA peers · ERNA filings
Documents published by the company on its investor-relations site; summaries are model-written. Not personalized investment advice.